ITMI20000312A0 - Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva - Google Patents

Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva

Info

Publication number
ITMI20000312A0
ITMI20000312A0 IT2000MI000312A ITMI20000312A ITMI20000312A0 IT MI20000312 A0 ITMI20000312 A0 IT MI20000312A0 IT 2000MI000312 A IT2000MI000312 A IT 2000MI000312A IT MI20000312 A ITMI20000312 A IT MI20000312A IT MI20000312 A0 ITMI20000312 A0 IT MI20000312A0
Authority
IT
Italy
Prior art keywords
treatment
chronic obstructive
formulations containing
lung disease
obstructive lung
Prior art date
Application number
IT2000MI000312A
Other languages
English (en)
Inventor
David Lewis
Gaetano Brambilla
David Ganderton
Brian Meakin
Alessandra Ferraris
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of ITMI20000312A0 publication Critical patent/ITMI20000312A0/it
Priority to IT2000MI000312A priority Critical patent/IT1317846B1/it
Priority to EP01919303A priority patent/EP1257254B1/en
Priority to BR0108584-0A priority patent/BR0108584A/pt
Priority to DE60114571T priority patent/DE60114571T2/de
Priority to CA002400691A priority patent/CA2400691A1/en
Priority to AU46450/01A priority patent/AU776742B2/en
Priority to SI200130442T priority patent/SI1257254T1/sl
Priority to PCT/EP2001/001833 priority patent/WO2001062227A2/en
Priority to DK01919303T priority patent/DK1257254T3/da
Priority to AT01919303T priority patent/ATE308317T1/de
Priority to ES01919303T priority patent/ES2249424T3/es
Priority to US10/204,307 priority patent/US6964759B2/en
Priority to JO200126A priority patent/JO2381B1/en
Publication of ITMI20000312A1 publication Critical patent/ITMI20000312A1/it
Application granted granted Critical
Publication of IT1317846B1 publication Critical patent/IT1317846B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT2000MI000312A 2000-02-22 2000-02-22 Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. IT1317846B1 (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IT2000MI000312A IT1317846B1 (it) 2000-02-22 2000-02-22 Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
SI200130442T SI1257254T1 (sl) 2000-02-22 2001-02-19 Farmacevtske oblike, ki vsebujejo antiholinergicno zdravilo za zdravljenje kronicne obstruktivne bolezni pljuc
DK01919303T DK1257254T3 (da) 2000-02-22 2001-02-19 Formuleringer indeholdende et anticholinergt lægemiddel til behandling af kronisk obstruktiv lungesygdom
DE60114571T DE60114571T2 (de) 2000-02-22 2001-02-19 Formulierungen, enthaltend einen anticholinergen Wirkstoff für die Behandlung der chronisch obstruktiven pulmonalen Erkrankung
CA002400691A CA2400691A1 (en) 2000-02-22 2001-02-19 Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease
AU46450/01A AU776742B2 (en) 2000-02-22 2001-02-19 Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease
EP01919303A EP1257254B1 (en) 2000-02-22 2001-02-19 Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease
PCT/EP2001/001833 WO2001062227A2 (en) 2000-02-22 2001-02-19 Anticholinergic drug formulations for treatment of chronic obstr uctive pulmonary disease
BR0108584-0A BR0108584A (pt) 2000-02-22 2001-02-19 Formulações contendo um fármaco anticolinérgico para o tratamento da broncopneumopatia crÈnica obtrutiva
AT01919303T ATE308317T1 (de) 2000-02-22 2001-02-19 Zubereitungen mit einem anticholinergischen wirkstoff für die behandlung der chronischen obstruktiven lungenerkrankung
ES01919303T ES2249424T3 (es) 2000-02-22 2001-02-19 Formulaciones que contienen un farmaco anticolinergico para el tratamiento de bronconeumopatias cronicas obstructivas.
US10/204,307 US6964759B2 (en) 2000-02-22 2001-02-19 Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease
JO200126A JO2381B1 (en) 2000-02-22 2001-02-20 Formulation containing anticholinergic drug for the treatment of chronic obstructive pulmonary disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI000312A IT1317846B1 (it) 2000-02-22 2000-02-22 Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.

Publications (3)

Publication Number Publication Date
ITMI20000312A0 true ITMI20000312A0 (it) 2000-02-22
ITMI20000312A1 ITMI20000312A1 (it) 2001-08-22
IT1317846B1 IT1317846B1 (it) 2003-07-15

Family

ID=11444121

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000MI000312A IT1317846B1 (it) 2000-02-22 2000-02-22 Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.

Country Status (12)

Country Link
US (1) US6964759B2 (it)
EP (1) EP1257254B1 (it)
AT (1) ATE308317T1 (it)
AU (1) AU776742B2 (it)
BR (1) BR0108584A (it)
CA (1) CA2400691A1 (it)
DE (1) DE60114571T2 (it)
DK (1) DK1257254T3 (it)
ES (1) ES2249424T3 (it)
IT (1) IT1317846B1 (it)
JO (1) JO2381B1 (it)
WO (1) WO2001062227A2 (it)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317720B1 (it) * 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
BR0015884A (pt) * 2000-05-22 2003-07-08 Chiesi Farma Spa Formulações de soluções farmacêuticas estáveis para inaladores de dose medida pressurizados
PT1273292E (pt) * 2001-07-02 2004-10-29 Chiesi Farma Spa Formulacao optimizada de tobramicina para aerossolizacao
EP1321159A1 (en) * 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
US7255102B2 (en) * 2002-02-01 2007-08-14 Generex Pharmaceuticals Inc. Metered dose spray device for use with macromolecular pharmaceutical agents such as insulin
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
PT3384931T (pt) * 2002-03-01 2019-09-26 Chiesi Farm Spa Formulaçâo superfina de formoterol
EP1415647A1 (en) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. "Long-acting beta-2 agonists ultrafine formulations"
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
US20040102469A1 (en) * 2002-09-13 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for reducing the mortality rate
WO2005037949A2 (en) 2003-10-07 2005-04-28 Chrysalis Technologies Incorporated Aerosol formulations of butalbital, lorazepam, ipratropium, baclofen, morphine and scopolamine
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
AU2005290068A1 (en) * 2004-09-24 2006-04-06 3M Innovative Properties Company Medicinal aerosol formulations and methods of synthesizing ingredients therefor
DE102006023770A1 (de) * 2006-05-20 2007-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treibgasfreie Aerosolformulierung für die Inhalation
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
WO2010133294A2 (de) 2009-05-18 2010-11-25 Boehringer Ingelheim International Gmbh Adapter, inhalationseinrichtung und zerstäuber
TWI792140B (zh) 2009-05-29 2023-02-11 美商沛爾醫療股份有限公司 用於經由呼吸道遞送二或更多種活性藥劑的組成物、方法與系統
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
DK2501363T3 (en) * 2009-11-17 2015-03-23 Cipla Ltd inhalable
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
MX2012005961A (es) 2009-11-25 2012-06-14 Boehringer Ingelheim Int Nebulizador.
EP2504051B1 (en) 2009-11-25 2019-09-04 Boehringer Ingelheim International GmbH Nebulizer
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
TR201902687T4 (tr) 2013-03-15 2019-03-21 Pearl Therapeutics Inc İri parçacıklı kristal malzemelerin koşullandırılması için yöntemler ve sistemler.
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US20170216286A1 (en) 2014-01-28 2017-08-03 Mayo Foundation For Medical Education And Research Killing senescent cells and treating senescence-associated conditions using a src inhibitor and a flavonoid
US10328058B2 (en) 2014-01-28 2019-06-25 Mayo Foundation For Medical Education And Research Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques
US9993472B2 (en) 2014-01-28 2018-06-12 Unity Biotechnology, Inc. Treatment for osteoarthritis in a joint by administering a means for inhibiting MDM2
ES2874029T3 (es) 2014-05-07 2021-11-04 Boehringer Ingelheim Int Nebulizador
MX2016014399A (es) 2014-05-07 2017-01-20 Boehringer Ingelheim Int Nebulizador.
EP3139979B1 (en) 2014-05-07 2023-07-05 Boehringer Ingelheim International GmbH Unit, nebulizer and method

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361306A (en) 1966-03-31 1968-01-02 Merck & Co Inc Aerosol unit dispensing uniform amounts of a medically active ingredient
US3622053A (en) 1969-12-10 1971-11-23 Schering Corp Aerosol inhaler with flip-up nozzle
MX3864E (es) 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
US4185100A (en) 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
US4499108A (en) 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
IT1196142B (it) 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
US5192528A (en) 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
AU8642391A (en) 1990-12-19 1992-07-22 Smithkline Beecham Corporation Aerosol formulations
US6006745A (en) 1990-12-21 1999-12-28 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
ES2122999T3 (es) 1991-05-21 1999-01-01 Abbott Lab Dispositivo de inhalacion en aerosol.
AU653634B2 (en) 1991-08-29 1994-10-06 Broncho-Air Medizintechnik Ag Medical appliance for inhaling metered aerosols
IL103238A (en) 1991-09-25 1995-07-31 Fisons Plc Pressed aerosol preparations
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
JP3908269B2 (ja) 1991-12-18 2007-04-25 スリーエム カンパニー 懸濁エアゾール製剤
DE4230876A1 (de) 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
DE69324161T2 (de) 1992-12-09 1999-10-28 Boehringer Ingelheim Pharma Stabilisierte medizinische aerosollösungen
SE9203743D0 (sv) 1992-12-11 1992-12-11 Astra Ab Efficient use
AU4066693A (en) 1992-12-23 1994-07-19 Bernhard Hugemann Compacted drug body for use in the mechanical generation of inhalable active-substance particles
AU679510B2 (en) 1993-03-17 1997-07-03 Minnesota Mining And Manufacturing Company Aerosol formulation containing a diol-diacid derived dispersing aid
WO1994021229A1 (en) 1993-03-17 1994-09-29 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
US6596260B1 (en) 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
WO1995017195A1 (en) 1993-12-20 1995-06-29 Minnesota Mining And Manufacturing Company Flunisolide aerosol formulations
GB9425160D0 (en) 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
CZ288146B6 (en) 1994-12-22 2001-05-16 Astra Ab Pharmaceutical aerosol preparation, process of its preparation and use
GB9426252D0 (en) 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition
DE4446891A1 (de) 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
US5653961A (en) 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
CZ292578B6 (cs) 1995-04-14 2003-10-15 Glaxo Wellcome Inc. Inhalátor, inhalační systém
JP3573213B2 (ja) 1995-04-14 2004-10-06 グラクソ、ウェルカム、インコーポレーテッド ベクロメタゾンジプロピオネート用計量投与用吸入器
ATE250439T1 (de) 1995-04-14 2003-10-15 Smithkline Beecham Corp Dosierinhalator für salmeterol
JPH11503352A (ja) * 1995-04-14 1999-03-26 グラクソ、ウェルカム、インコーポレーテッド プロピオン酸フルチカゾン用計量投与用吸入器
GB9612297D0 (en) 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
JP2000514085A (ja) 1996-07-08 2000-10-24 ローヌ―プーラン・ロウラー・リミテッド 医薬シクロスポリンａエーロゾル溶液処方物
WO1998003533A1 (en) 1996-07-24 1998-01-29 Oligos Etc. And Oligos Therapeutics, Inc. Antisense oligonucleotides as antibacterial agents
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB9620187D0 (en) 1996-09-27 1996-11-13 Minnesota Mining & Mfg Medicinal aerosol formulations
EP1011646B1 (en) 1996-12-04 2005-08-17 Link Products Limited Pharmaceutical compositions and devices for their administration
US6413496B1 (en) * 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
JP2001511160A (ja) 1997-02-05 2001-08-07 ヤゴ リサーチ アクチェンゲゼルシャフト 医学用エアゾール配合物
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US5891419A (en) 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
GB2326334A (en) 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
BR7702049U (pt) 1997-09-05 1999-09-14 Chiesi Farma Spa Bico pulverizador para utilização em inalador oral para medicamentos aerossóis
US5954047A (en) 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
US6045784A (en) 1998-05-07 2000-04-04 The Procter & Gamble Company Aerosol package compositions containing fluorinated hydrocarbon propellants
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
WO1999065464A1 (en) 1998-06-18 1999-12-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6241969B1 (en) 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
CA2338753C (en) 1998-07-24 2006-11-21 Jago Research Ag Medicinal aerosol formulations
DK1102579T3 (da) 1998-08-04 2003-07-14 Jago Res Ag Medicinske aerosolformuleringer
SK285382B6 (sk) 1998-10-17 2006-12-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Skladovateľný koncentrát s obsahom formoterolu, prípravok s jeho obsahom a jeho použitie
DE19847969A1 (de) 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
AU756852B2 (en) 1998-11-13 2003-01-23 Jagotec Ag Dry powder for inhalation
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
BR9917246A (pt) 1999-03-05 2002-03-26 Chiesi Farma Spa Composições farmacêuticas avançadas em pó para inalação
US6315985B1 (en) 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
DE60019167T2 (de) 1999-12-24 2006-05-11 Glaxo Group Ltd., Greenford Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
US20030190278A1 (en) * 2002-04-08 2003-10-09 Yan Mei Wang Controlled deposition of nanotubes

Also Published As

Publication number Publication date
DE60114571T2 (de) 2006-06-08
BR0108584A (pt) 2003-03-25
US6964759B2 (en) 2005-11-15
AU4645001A (en) 2001-09-03
CA2400691A1 (en) 2001-08-30
EP1257254A2 (en) 2002-11-20
ES2249424T3 (es) 2006-04-01
ITMI20000312A1 (it) 2001-08-22
JO2381B1 (en) 2006-12-12
IT1317846B1 (it) 2003-07-15
DK1257254T3 (da) 2006-03-20
ATE308317T1 (de) 2005-11-15
WO2001062227A2 (en) 2001-08-30
AU776742B2 (en) 2004-09-23
EP1257254B1 (en) 2005-11-02
WO2001062227A3 (en) 2002-03-07
US20030157028A1 (en) 2003-08-21
DE60114571D1 (de) 2005-12-08

Similar Documents

Publication Publication Date Title
ITMI20000312A0 (it) Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva
CY2019030I2 (el) Παραγωγο ραπαμυκινης για την θεραπευτικη αντιμετωπιση του καρκινου του πνευμονα
HUS1400011I1 (hu) Új gyógyszer krónikus elzáródásos tüdõbetegség kezelésére
IL160884A0 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
SI1390023T1 (sl) Farmacevtske soli spojin 1-fenil-3-dimetilamino-propana
IL196301A0 (en) Medicament for the treatment of hapatitis c
EE200200716A (et) Ühendid Alzheimeri tõve käitluseks
NO20033594D0 (no) Fenetanolamin-derivater for behandling av luftveissykdommer
HK1116339A1 (en) Methods of administering epothilone analogs for the treatment of cancer
EP1311261A4 (en) MEDICAMENTS FOR THE CHEMOTHERAPEUTIC TREATMENT OF DISEASES
EE200300537A (et) Meetod madalaannuselise farmatseutilise kompositsiooni tootmiseks
ITMI20001051A0 (it) Formulazioni contenenti un farmaco glucocorticosteroide per il trattamento di patologie broncopolmonari
EE200300501A (et) Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid
FI20000780A (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
HUP0400115A3 (en) Pharmaceutical composition for the intramuscular administration of fulvestrant
ITMI20020773A0 (it) Farmaci per il trattamento dell'artrite
IL153831A (en) Pharmaceutical composition for therapy of neurodegenerative disease of the brain
AU2002338303A1 (en) Therapeutic compositions for the treatment of a respiratory tract disease
IL143636A0 (en) Diazepinoindoles for the treatment of chronic obstructive pulmonary disease
NO20032006L (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
HRP20030677A2 (en) Methods of administering epothilone analogs for the treatment of cancer
HK1077216A1 (en) Use of thiazole derivatives for the manufacture ofa medicament for the treatment of chronic obstruc tive pulmonary disease
AU4335901A (en) Novel therapeutic treatment of chronic obstructive pulmonary disease
SI1257254T1 (sl) Farmacevtske oblike, ki vsebujejo antiholinergicno zdravilo za zdravljenje kronicne obstruktivne bolezni pljuc
AU2002348105A1 (en) Oral dosage forms for improving the bioavailability of therapeutic agents